$BKYI
BIO KEY INTERNATIONAL INC Stock $bkyi

$bkyi Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-Q Financial Statement

#000143774923017071 Filed on June 09, 2023

Income Statement

Concept	2023 Q1	2022 Q1
Revenue	$3.084M	$1.941M
YoY Change	58.86%	2.78%
Cost Of Revenue	$820.3K	$337.4K
YoY Change	143.09%	-55.98%
Gross Profit	$2.263M	$1.604M
YoY Change	41.14%	42.93%
Gross Profit Margin	73.4%	82.62%
Selling, General & Admin	$1.932M	$1.798M
YoY Change	7.44%	18.57%
% of Gross Profit	85.34%	112.11%
Research & Development	$690.2K	$805.3K
YoY Change	-14.29%	82.33%
% of Gross Profit	30.49%	50.21%
Depreciation & Amortization	$13.24K	$11.22K
YoY Change	18.02%	-55.33%
% of Gross Profit	0.59%	0.7%
Operating Expenses	$2.622M	$2.603M
YoY Change	0.72%	32.95%
Operating Profit	-$358.4K	-$999.5K
YoY Change	-64.14%	19.55%
Interest Expense	$56.92K	$0.00
YoY Change		-100.0%
% of Operating Profit
Other Income/Expense, Net	$70.08K	$131.00
YoY Change	53393.13%	-100.85%
Pretax Income	-$526.5K	-$999.4K
YoY Change	-47.32%	17.58%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$288.3K	-$999.4K
YoY Change	-71.15%	17.38%
Net Earnings / Revenue	-9.35%	-51.48%
Basic Earnings Per Share	-$0.03	-$0.13
Diluted Earnings Per Share	-$0.06	-$126.7K
COMMON SHARES
Basic Shares Outstanding	8.944M	7.885M
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$667.7K	$5.801M
YoY Change	-88.49%	-58.68%
Cash & Equivalents	$722.3K	$5.801M
Short-Term Investments
Other Short-Term Assets	$82.50K	$51.85K
YoY Change	59.11%	4.1%
Inventory	$4.428M	$4.956M
Prepaid Expenses
Receivables	$3.362M	$2.553M
Other Receivables	$57.75K	$133.9K
Total Short-Term Assets	$8.936M	$13.81M
YoY Change	-35.27%	-22.13%
LONG-TERM ASSETS
Property, Plant & Equipment	$94.17K	$129.2K
YoY Change	-27.09%	84.55%
Goodwill		$1.721M
YoY Change		36.3%
Intangibles	$1.682M	$2.647M
YoY Change	-36.47%	81.27%
Long-Term Investments		$452.8K
YoY Change
Other Assets	$263.0K	$288.5K
YoY Change	-8.84%	60.28%
Total Long-Term Assets	$2.170M	$5.597M
YoY Change	-61.23%	49.12%
TOTAL ASSETS
Total Short-Term Assets	$8.936M	$13.81M
Total Long-Term Assets	$2.170M	$5.597M
Total Assets	$11.11M	$19.40M
YoY Change	-42.76%	-9.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.210M	$1.014M
YoY Change	19.3%	227.9%
Accrued Expenses	$876.3K	$895.5K
YoY Change	-2.14%	67.08%
Deferred Revenue	$653.3K	$798.8K
YoY Change	-18.21%	52.21%
Short-Term Debt	$2.454M	$0.00
YoY Change
Long-Term Debt Due	$134.9K	$123.0K
YoY Change	9.67%
Total Short-Term Liabilities	$5.425M	$3.488M
YoY Change	55.53%	117.99%
LONG-TERM LIABILITIES
Long-Term Debt	$277.6K	$423.7K
YoY Change	-34.49%
Other Long-Term Liabilities	$73.34K	$109.4K
YoY Change	-32.97%	-57.92%
Total Long-Term Liabilities	$523.9K	$533.1K
YoY Change	-1.73%	104.4%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.425M	$3.488M
Total Long-Term Liabilities	$523.9K	$533.1K
Total Liabilities	$5.949M	$4.021M
YoY Change	47.94%	116.09%
SHAREHOLDERS EQUITY
Retained Earnings	-$116.8M	-$105.6M
YoY Change	10.61%	5.19%
Common Stock	$922.00	$841.00
YoY Change	9.63%	7.54%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.157M	$15.38M
YoY Change
Total Liabilities & Shareholders Equity	$11.11M	$19.40M
YoY Change	-42.76%	-9.68%

Cashflow Statement

Concept	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$288.3K	-$999.4K
YoY Change	-71.15%	17.38%
Depreciation, Depletion And Amortization	$13.24K	$11.22K
YoY Change	18.02%	-55.33%
Cash From Operating Activities	-$1.929M	-$1.434M
YoY Change	34.47%	-55.16%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$4.459K
YoY Change	-100.0%	-66.49%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$540.6K
YoY Change	-100.0%
Cash From Investing Activities	$0.00	-$545.0K
YoY Change	-100.0%	3995.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$34.29K	$0.00
YoY Change		-100.0%
NET CHANGE
Cash From Operating Activities	-$1.929M	-$1.434M
Cash From Investing Activities	$0.00	-$545.0K
Cash From Financing Activities	-$34.29K	$0.00
Net Change In Cash	-$1.913M	-$1.953M
YoY Change	-2.03%	-43.63%
FREE CASH FLOW
Cash From Operating Activities	-$1.929M	-$1.434M
Capital Expenditures	$0.00	$4.459K
Free Cash Flow	-$1.929M	-$1.439M
YoY Change	34.05%	-55.2%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	41-1741861
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	3349 HIGHWAY 138, BUILDING A, SUITE E
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	WALL
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07719
CY2023Q1	dei	City Area Code CityAreaCode	732
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	359-1100
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001019034
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	1-13463
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	BIO-KEY INTERNATIONAL, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Trading Symbol TradingSymbol	BKYI
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9234833
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	722335	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2635522	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3362203	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1522784	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	82500	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	49500	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	4427815	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	4434369	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	341231	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	342706	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	8936084	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	8984881	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	94170	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	107413	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	254279	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	283069	usd
CY2023Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8712	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	8712	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	131223	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	197355	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1681589	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1762825	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	2169973	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	2359374	usd
CY2023Q1	us-gaap	Assets Assets	11106057	usd
CY2022Q4	us-gaap	Assets Assets	11344255	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1210070	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1108279	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	876287	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1009123	usd
CY2023Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	2454212	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	2596203	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	134899	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	120000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	653338	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	462418	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	96584	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	159665	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	5425390	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5455688	usd
CY2023Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	39969	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	52134	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	172997	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	170281	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	277580	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	326767	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	33366	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	37829	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	523912	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	587011	usd
CY2023Q1	us-gaap	Liabilities Liabilities	5949302	usd
CY2022Q4	us-gaap	Liabilities Liabilities	6042699	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9226058
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9226058
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9190504
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9190504
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	922	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	919	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	122099984	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	122028612	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-170456	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-242602	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-116773695	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-116485373	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	5156755	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5301556	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11106057	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11344255	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3083767	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1941171	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	820274	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	337441	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	2263493	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	1603730	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1931732	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1797998	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	690159	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	805266	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	2621891	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	2603264	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-358398	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-999534	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	4	usd
CY2022Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	131	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-15000	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	0	usd
CY2023Q1	bkyi	Fair Value Adjustment Of Convertible Note FairValueAdjustmentOfConvertibleNote	-141991	usd
CY2022Q1	bkyi	Fair Value Adjustment Of Convertible Note FairValueAdjustmentOfConvertibleNote	-0	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	56919	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	-0	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	70076	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	131	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-288322	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-999403	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-288322	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-999403	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	72146	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	55802	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-216176	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-943601	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8944485
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7885008
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5301556	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	12002	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	4	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	3105	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	72146	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	62474	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-288322	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	5156755	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	15615455	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	22020	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	600004	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	55802	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	87677	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-999403	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	15381555	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-288322	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-999403	usd
CY2023Q1	us-gaap	Depreciation Depreciation	13242	usd
CY2022Q1	us-gaap	Depreciation Depreciation	11220	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	81237	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	54231	usd
CY2023Q1	bkyi	Fair Value Adjustment Of Convertible Note FairValueAdjustmentOfConvertibleNote	-141991	usd
CY2022Q1	bkyi	Fair Value Adjustment Of Convertible Note FairValueAdjustmentOfConvertibleNote	0	usd
CY2023Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	37529	usd
CY2022Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	35658	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	66132	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	51587	usd
CY2023Q1	bkyi	Stock Based Fees To Directors And Consultants StockBasedFeesToDirectorsAndConsultants	12002	usd
CY2022Q1	bkyi	Stock Based Fees To Directors And Consultants StockBasedFeesToDirectorsAndConsultants	22020	usd
CY2023Q1	bkyi	Share Based Compensation Excluding Directors Fees ShareBasedCompensationExcludingDirectorsFees	59373	usd
CY2022Q1	bkyi	Share Based Compensation Excluding Directors Fees ShareBasedCompensationExcludingDirectorsFees	87677	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	usd
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	25111	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1798881	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	904930	usd
CY2023Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	33000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	2350	usd
CY2023Q1	bkyi	Increase Decrease In Capitalized Contract Costs IncreaseDecreaseInCapitalizedContractCosts	8739	usd
CY2022Q1	bkyi	Increase Decrease In Capitalized Contract Costs IncreaseDecreaseInCapitalizedContractCosts	66435	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-6554	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	15812	usd
CY2023Q1	bkyi	Increase Decrease In Software License Rights IncreaseDecreaseInSoftwareLicenseRights	0	usd
CY2022Q1	bkyi	Increase Decrease In Software License Rights IncreaseDecreaseInSoftwareLicenseRights	2505	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2219	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	124616	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	88040	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	175341	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-135417	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	45669	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	178755	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	220874	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-67544	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-52722	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1928811	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1434375	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	-0	usd
CY2022Q1	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	543578	usd
CY2023Q1	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	usd
CY2022Q1	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	3000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	-0	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4459	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-545037	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt	-34289	usd
CY2022Q1	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-34289	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	49913	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	26487	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1913187	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1952925	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2635522	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7754046	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	722335	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5801121	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	56919	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023Q1	bkyi	Business Combination Accounts Receivable Acquired BusinessCombinationAccountsReceivableAcquired	0	usd
CY2022Q1	bkyi	Business Combination Accounts Receivable Acquired BusinessCombinationAccountsReceivableAcquired	702886	usd
CY2023Q1	bkyi	Business Combination Equipment Acquired BusinessCombinationEquipmentAcquired	0	usd
CY2022Q1	bkyi	Business Combination Equipment Acquired BusinessCombinationEquipmentAcquired	65640	usd
CY2023Q1	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1	0	usd
CY2022Q1	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1	20708	usd
CY2023Q1	bkyi	Business Combination Intangible Assets Acquired BusinessCombinationIntangibleAssetsAcquired	0	usd
CY2022Q1	bkyi	Business Combination Intangible Assets Acquired BusinessCombinationIntangibleAssetsAcquired	1379589	usd
CY2023Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	usd
CY2022Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	450643	usd
CY2023Q1	bkyi	Noncash Or Part Noncash Acquisition Accrued Expenses And Other Liabilities Assumed NoncashOrPartNoncashAcquisitionAccruedExpensesAndOtherLiabilitiesAssumed	0	usd
CY2022Q1	bkyi	Noncash Or Part Noncash Acquisition Accrued Expenses And Other Liabilities Assumed NoncashOrPartNoncashAcquisitionAccruedExpensesAndOtherLiabilitiesAssumed	431884	usd
CY2023Q1	bkyi	Government Loan Acquired GovernmentLoanAcquired	0	usd
CY2022Q1	bkyi	Government Loan Acquired GovernmentLoanAcquired	544000	usd
CY2023Q1	bkyi	Noncash Or Part Noncash Acquisition Stock Issued Amount NoncashOrPartNoncashAcquisitionStockIssuedAmount	0	usd
CY2022Q1	bkyi	Noncash Or Part Noncash Acquisition Stock Issued Amount NoncashOrPartNoncashAcquisitionStockIssuedAmount	600004	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3083767	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1941171	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	693000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	515000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	223000	usd
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	234000	usd
CY2023Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	3985988	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	2096569	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	623785	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	573785	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3362203	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1522784	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	71375	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	109697	usd
CY2023Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	4758089	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	4764643	usd
CY2023Q1	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	69726	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	69726	usd
CY2023Q1	bkyi	Inventory Finished Goods Reserves InventoryFinishedGoodsReserves	400000	usd
CY2022Q4	bkyi	Inventory Finished Goods Reserves InventoryFinishedGoodsReserves	400000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	4427815	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	4434369	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	63139	usd
CY2022Q1	us-gaap	Lease Cost LeaseCost	55219	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	131223	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	197355	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	96584	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	159665	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	33366	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	37829	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	129950	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	197494	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y7M28D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y11M15D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0550	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0550	pure
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	69821	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	65108	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	95911	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	38808	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	134719	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	4769	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	129950	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2022Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd

Files In Submission

Name	View Source	Status
ex_523027.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
0001437749-23-017071-index-headers.html	Edgar Link	pending
0001437749-23-017071-index.html	Edgar Link	pending
0001437749-23-017071.txt	Edgar Link	pending
0001437749-23-017071-xbrl.zip	Edgar Link	pending
bkyi-20230331.xsd	Edgar Link	pending
bkyi20230331_10q.htm	Edgar Link	pending
ex_523024.htm	Edgar Link	pending
ex_523025.htm	Edgar Link	pending
ex_523026.htm	Edgar Link	pending
bkyi-20230331_cal.xml	Edgar Link	unprocessable
bkyi-20230331_pre.xml	Edgar Link	unprocessable
bkyi-20230331_lab.xml	Edgar Link	unprocessable
bkyi-20230331_def.xml	Edgar Link	unprocessable
bkyi20230331_10q_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BKYI
BIO KEY INTERNATIONAL INC Stock $bkyi

2023 Q1 Form 10-Q Financial Statement

#000143774923017071 Filed on June 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BKYI BIO KEY INTERNATIONAL INC Stock $bkyi

2023 Q1 Form 10-Q Financial Statement

#000143774923017071 Filed on June 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BKYI
BIO KEY INTERNATIONAL INC Stock $bkyi